Journal of Affective Disorders
Volume 85, Issue 3 , Pages 317-321 , April 2005

Luteal phase treatment of premenstrual dysphoric disorder improves symptoms that continue into the postmenstrual phase

Received 26 April 2004 ,Accepted 14 October 2004.

References 

  1. Cohen LS, Miner C, Brown EW, Freeman E, Halbreich U, Sundell K, et al. Premenstrual daily fluoxetine for premenstrual dysphoric disorder: a placebo-controlled, clinical trial using computerized diaries. Obstet. Gynecol. 2002;100:435–444
  2. Halbreich U, Bergeron R, Yonkers KA, Freeman E, Stout AL, Cohen L. Efficacy of intermittent, luteal phase sertraline treatment of premenstrual dysphoric disorder. Obstet. Gynecol. 2002;100:1219–1229
  3. Hindmarch I, Kimber S, Cockle SM. Abrupt and brief discontinuation of antidepressant treatment: effects on cognitive function and psychomotor performance. Int. Clin. Psychopharmacol. 2000;15:305–318
  4. Judge R, Parry MG, Quail D, Jacobson JG. Discontinuation symptoms: comparison of brief interruption in fluoxetine and paroxetine treatment. Int. Clin. Psychopharmacol. 2002;17:217–225
  5. Michelson D, Fava M, Amsterdam J, Apter J, Londborg P, Tamura R, et al. Interruption of selective serotonin reuptake inhibitor treatment. Double-blind, placebo-controlled trial. Br. J. Psychiatry. 2000;176:363–368
  6. Pearlstein T, Yonkers KA, Fayyad R, Gillespie JA. Pretreatment pattern of symptom expression in premenstrual dysphoric disorder. J. Affect. Disord. 2005;85:275–282
  7. Rosenbaum JF, Fava M, Hoog SL, Ascroft RC, Krebs WB. Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial. Biol. Psychiatry. 1998;44:77–87
  8. Wyatt, KM., Dimmock, PW., O'Brien, P.M.S., 2003. Selective serotonin reuptake inhibitors for premenstrual syndrome. Cochrane Database of Systematic Reviews. 3 (date of most recent amendment, 08-28-2002).
  9. Yonkers KA, Halbreich U, Freeman E, Brown C, Endicott J, Frank E, et al. Symptomatic improvement of premenstrual dysphoric disorder with sertraline treatment. A randomized controlled trial. JAMA. 1997;278:983–988

PII: S0165-0327(04)00369-6

doi: 10.1016/j.jad.2004.10.006

Journal of Affective Disorders
Volume 85, Issue 3 , Pages 317-321 , April 2005

Article Tools

* Image Usage & Resolution